SCHEMBL24712976

SCHEMBL24712976

CCOC(=O)c1cnn2ccc(C)c(Br)c12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 8/20 0.46
▸ HPGD P15428 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ TSHR P16473 3/20 0.45
▸ NPC1 O15118 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25423311 0.87 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL16309064 0.86 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL1702035 0.86 KDM4E (0.44) SMN1; SMN2ALDH1A1HPGDRAB9ATSHR
SCHEMBL25780650 0.86 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL16309075 0.85 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL16309072 0.84 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL15017169 0.82 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL24713047 0.82 DRD2 (0.48) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2
SCHEMBL1701947 0.81 L3MBTL1 (0.40) SMN1; SMN2ALDH1A1RAB9ANPC1LMNA
SCHEMBL25786093 0.81 DRD2 (0.53) SMN1; SMN2ALDH1A1HPGDRAB9ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116779-A1 DIALKYNE COMPOUND AND USE THEREOF 上海艾力斯医药科技股份有限公司 2023-06-29 — — WO disclosed
EP-4092024-A1 PYRIMIDINE-4(3H)-KETONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE AND PHARMACOLOGY Beijing InnoCare Pharma Tech Co., Ltd. (CN) 2022-11-23 — — EP disclosed
Send feedback